Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers-Reference-Cited by-同舟云学术

Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers

Published:2021-01 Issue: Volume:497 Page:123-136
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Oh Yumi,Jung Hae Rim,Min Seoyeon,Kang Jinjoo,Jang Dongjun,Shin Seungjae,Kim Jiwon,Lee Sang Eun,Sung Chang Ohk,Lee Won-Suk,Lee Charles,Jeong Eui Man,Cho Sung-Yup

Funder

National Research Foundation of Korea

Ministry of Education

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference60 articles.

1. Reactive oxygen species-mediated mechanisms of action of targeted cancer therapy;Teppo;Oxid. Med. Cell Longev.,2017

2. Reactive oxygen species: a key constituent in cancer survival;Kumari;Biomark. Insights,2018

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Bray;Cancer J. Clin.,2018

4. Targeted therapy in metastatic colorectal cancer: current standards and novel agents in review;DeStefanis;Curr. Colorectal Cancer Rep.,2019

5. Association between molecular subtypes of colorectal cancer and patient survival;Phipps;Gastroenterology,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutathione Dynamics in the Tumor Microenvironment: A Potential Target of Cancer Stem Cells and T Cells;International Journal of Stem Cells;2024-06-26

2. Nanoplatform-based cellular reactive oxygen species regulation for enhanced oncotherapy and tumor resistance alleviation;Chinese Chemical Letters;2023-09

3. Antiphotoaging and Skin-Protective Activities of Ardisia silvestris Ethanol Extract in Human Keratinocytes;Plants;2023-03-03

4. KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration;Journal of Clinical Medicine;2023-01-16

5. Syk promotes phagocytosis by inducing reactive oxygen species generation and suppressing SOCS1 in macrophage-mediated inflammatory responses;International Journal of Immunopathology and Pharmacology;2022-01